Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Unnecessary Antipsychotic Medication Prescribed for Dementia

Collinsville, Oklahoma Survey Completed on 08-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency was identified when a resident was prescribed and administered Seroquel, an antipsychotic medication, for the diagnosis of unspecified dementia with behavioral disturbances and anxiety. Facility policy states that antipsychotic medications should only be used when necessary to treat specific, indicated conditions. However, the medication administration record showed the resident received Seroquel twice daily over several days for dementia, a diagnosis for which the medication is not approved. Staff interviews revealed that the primary behaviors observed were attempts by the resident to leave the facility and statements about needing to go to work. Further interviews with a certified medication aide, an LPN, and the DON confirmed that the medication was being used for dementia-related behaviors and anxiety. The DON acknowledged awareness that CMS does not approve Seroquel for the treatment of dementia and that the resident had been on the medication since admission for these behaviors. The documentation and staff responses did not indicate a specific, approved psychiatric diagnosis justifying the use of the antipsychotic, resulting in the finding of unnecessary medication use.

An unhandled error has occurred. Reload 🗙